Free Trial

Agios Pharmaceuticals (AGIO) Competitors

Agios Pharmaceuticals logo
$36.28 +1.07 (+3.04%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$35.06 -1.23 (-3.38%)
As of 07/8/2025 07:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AGIO vs. ROIV, ELAN, RVMD, LEGN, GRFS, TGTX, NUVL, LNTH, TLX, and AXSM

Should you be buying Agios Pharmaceuticals stock or one of its competitors? The main competitors of Agios Pharmaceuticals include Roivant Sciences (ROIV), Elanco Animal Health (ELAN), Revolution Medicines (RVMD), Legend Biotech (LEGN), Grifols (GRFS), TG Therapeutics (TGTX), Nuvalent (NUVL), Lantheus (LNTH), Telix Pharmaceuticals (TLX), and Axsome Therapeutics (AXSM). These companies are all part of the "pharmaceutical products" industry.

Agios Pharmaceuticals vs. Its Competitors

Roivant Sciences (NASDAQ:ROIV) and Agios Pharmaceuticals (NASDAQ:AGIO) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, analyst recommendations, institutional ownership and risk.

In the previous week, Agios Pharmaceuticals had 6 more articles in the media than Roivant Sciences. MarketBeat recorded 6 mentions for Agios Pharmaceuticals and 0 mentions for Roivant Sciences. Agios Pharmaceuticals' average media sentiment score of 0.28 beat Roivant Sciences' score of 0.00 indicating that Agios Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Roivant Sciences Neutral
Agios Pharmaceuticals Neutral

Roivant Sciences has a beta of 1.15, suggesting that its share price is 15% more volatile than the S&P 500. Comparatively, Agios Pharmaceuticals has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500.

Agios Pharmaceuticals has higher revenue and earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Agios Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Roivant Sciences$29.05M254.14-$171.98M-$0.25-43.44
Agios Pharmaceuticals$36.50M57.57$673.72M$11.243.23

Roivant Sciences currently has a consensus target price of $17.50, suggesting a potential upside of 61.14%. Agios Pharmaceuticals has a consensus target price of $58.60, suggesting a potential upside of 61.52%. Given Agios Pharmaceuticals' higher possible upside, analysts clearly believe Agios Pharmaceuticals is more favorable than Roivant Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Roivant Sciences
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
Agios Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Agios Pharmaceuticals has a net margin of 1,798.26% compared to Roivant Sciences' net margin of -225.71%. Agios Pharmaceuticals' return on equity of -2.75% beat Roivant Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Roivant Sciences-225.71% -14.76% -13.69%
Agios Pharmaceuticals 1,798.26%-2.75%-2.52%

64.8% of Roivant Sciences shares are held by institutional investors. 7.9% of Roivant Sciences shares are held by company insiders. Comparatively, 4.9% of Agios Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Agios Pharmaceuticals beats Roivant Sciences on 11 of the 17 factors compared between the two stocks.

Get Agios Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for AGIO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AGIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AGIO vs. The Competition

MetricAgios PharmaceuticalsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$2.04B$2.88B$5.47B$8.95B
Dividend YieldN/A2.46%5.25%4.06%
P/E Ratio3.2320.8027.0020.10
Price / Sales57.57286.98435.75120.29
Price / CashN/A41.1936.8257.86
Price / Book1.347.487.985.56
Net Income$673.72M-$55.04M$3.16B$248.40M
7 Day Performance2.63%2.44%2.40%4.67%
1 Month Performance7.78%1.90%2.19%6.64%
1 Year Performance-15.04%4.35%33.82%21.31%

Agios Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AGIO
Agios Pharmaceuticals
3.9657 of 5 stars
$36.28
+3.0%
$58.60
+61.5%
-11.9%$2.04B$36.50M3.23390
ROIV
Roivant Sciences
1.5177 of 5 stars
$11.27
-1.1%
$17.50
+55.3%
+1.3%$7.74B$29.05M-45.08860
ELAN
Elanco Animal Health
2.3486 of 5 stars
$14.29
flat
$15.17
+6.1%
+5.7%$7.10B$4.44B19.319,000
RVMD
Revolution Medicines
4.5646 of 5 stars
$36.79
-0.3%
$67.58
+83.7%
-7.9%$6.88B$11.58M-9.20250Positive News
LEGN
Legend Biotech
3.0504 of 5 stars
$35.49
+2.5%
$76.20
+114.7%
-20.9%$6.36B$627.24M-60.152,609Positive News
Analyst Forecast
GRFS
Grifols
4.0825 of 5 stars
$9.04
+2.0%
$10.30
+13.9%
+7.0%$6.09B$7.81B7.7323,822News Coverage
Analyst Upgrade
TGTX
TG Therapeutics
3.89 of 5 stars
$35.99
-2.0%
$40.80
+13.4%
+82.1%$5.83B$329M149.96290News Coverage
Positive News
NUVL
Nuvalent
3.7406 of 5 stars
$76.30
-4.2%
$119.60
+56.7%
+8.9%$5.72BN/A-17.3840
LNTH
Lantheus
4.4152 of 5 stars
$81.86
+0.5%
$130.50
+59.4%
+4.6%$5.64B$1.53B23.26700
TLX
Telix Pharmaceuticals
N/A$16.07
+0.4%
$22.00
+36.9%
N/A$5.41B$516.72M0.00N/A
AXSM
Axsome Therapeutics
4.7718 of 5 stars
$104.39
+1.0%
$172.33
+65.1%
+29.6%$5.09B$385.69M-18.09380

Related Companies and Tools


This page (NASDAQ:AGIO) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners